✦ LIBER ✦

Multimodality approaches in breast cancer: what have we learned?

✍ Scribed by Bartelink, H.

Book ID: 123447330
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 138 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81628-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer 1985: What have we learned

Breast cancer 1985: What have we learned?

✍ Jerome A. Urban 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 1006 KB

A popular misconception infers that all breast cancers are systemic from their inception, that variations of primary therapy will not affect prognosis, and that an effective systemic therapy is already available. This is not so. Moderate improvement in long-term survival of breast cancer patients ha

Hereditary ovarian and breast cancer: wh

Hereditary ovarian and breast cancer: what have we learned?

✍ Lynch, H. T.; Snyder, C.; Casey, M. J. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 801 KB

Cancer clusters: what have we learned?

✍ Stewart, B. W. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Overview of trials done in breast cancer

Overview of trials done in breast cancer — what have we learned?

✍ H. Olsson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

The randomized trials of breast cancer s

The randomized trials of breast cancer screening: what have we learned?

✍ Smith, Robert A.; Duffy, Stephen W.; Gabe, Rhian; Tabar, Laszlo; Yen, Amy M.F.; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Hormone-refractory prostate cancer: what

Hormone-refractory prostate cancer: what have we learned?

✍ Manfred P. Wirth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB